Streptococcus pneumoniae vaccine - Affinivax
Alternative Names: Fusion protein antigen SPP2; MAPS Pneumococcal vaccine - Affinivax; MAPS Streptococcus pneumoniae vaccine - AffinivaxLatest Information Update: 28 May 2024
At a glance
- Originator Affinivax
- Class Conjugate vaccines; Pneumococcal vaccines; Streptococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Streptococcal infections
Highest Development Phases
- No development reported Streptococcal infections